Analysis of risk factors for the development of cardiovascular diseases in patients with rheumatoid arthritis, depending on gender

Saule Abisheva 1 2, Zhadra Amangeldiyeva 1, Zhanna Serikova 1 *
More Detail
1 No1 Family Medicine Department, Astana Medical University, Nur-Sultan city, Republic of Kazakhstan
2 No1 Family Medicine Department, Scientific Research Institute of Traumatology and Orthopedics, Nur-Sultan city, Republic of Kazakhstan
* Corresponding Author
J CLIN MED KAZ, Volume 2, Issue 56, pp. 34-40. https://doi.org/10.23950/1812-2892-JCMK-00745
OPEN ACCESS 1821 Views 1258 Downloads
Download Full Text (PDF)

ABSTRACT

Background: Rheumatoid arthritis is recognized to be an adverse risk factor of cardiovascular diseases.
Aim: To determine the structure and frequency of occurrence of traditional risk factors of cardiovascular diseases, depending on the gender of patients with rheumatoid arthritis.
Material and methods: The case histories of 70 patients (men n-23, women n-47) according to the criteria of the diagnosis of ACR / EULAR 2010 were analyzed. The SCORE scale was used to assess cardiovascular risk. In patients with rheumatoid arthritis duration of more than 10 years, seropositive for rheumatoid factor and antibodies to cyclic citrulline peptide, with systemic manifestations according to the recommendations of EULAR, an adapted SCORE/EULAR model is used; risk is recalculated taking into account the coefficient of 1.5. These studies were processed using statistical programs the Microsoft Office Excel 2010 and the IBM SPSS 21 program.
Results: Women with rheumatoid arthritis who smoke less (4.3%) than men (60.9%) at p <0.01. At the same time, the frequency of arterial hypertension is higher in men than in women (65.2% and 40.4%). In men the age factor is in the first row (78.3% and 44.4%, p <0.01). Depending on the gender of the patients, the difference  among other cardiovascular diseases risk factors was insignificant. The mean  of the total cholesterol (M ± SD) did not differ significantly between men and women (5.58 ± 0.98, 5.64 ± 0.91, p> 0.05). In the study, body weight index analysis showed that the body mass index of women were higher than  men (M±SD 28.1±6.3, 26.6±3.8). The difference in body mass index by gender was significant  (p <0.05). Depending on gender specificity, the mean value of systolic blood pressure/diastolic blood pressure was higher in men than in women (129±16.7/82.2±8.5 and 136.7±13.1/86 ± 7) and statistically significant (p <0.05). Women with low and middle risk of cardiovascular diseases prevailed (21.3% and 57.4%) than men (8.7% and 30.4%). The majority of men had a high and very high risk (21.7% and 39.1%), while women were in a smaller number (6.4% and 14.9%). There was a significant correlation between the men and women with the cardiovascular diseases risk, i.e, the p=0,012 (p <0,05) measured by the chi-squared criterion.
Conclusion: So, if the first step for prevention of cardiovascular diseases in the treatment of patients with rheumatoid arthritis is not sufficient correction of traditional risk factors, it is possible to develop complications of cardiovascular diseases. At the same time, the impact of rheumatoid arthritis on the development of cardiovascular diseases is obvious.
Keywords: cardiovascular risk, cardiovascular diseases, rheumatoid arthritis, gender

CITATION

Abisheva S, Amangeldiyeva Z, Serikova Z. Analysis of risk factors for the development of cardiovascular diseases in patients with rheumatoid arthritis, depending on gender. Journal of Clinical Medicine of Kazakhstan. 2020;2(56):34-40. https://doi.org/10.23950/1812-2892-JCMK-00745

REFERENCES

  • Gabriel SE The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am. 2001; 27(2):269-81. https://doi.org/10.1016/S0889-857X(05)70201-5
  • Isaeva BG, Saparbaeva MM, Habizhanova VB, Gabdulina GH, Esirkepova GS, Kajyrgali SHM, Isaeva SM, Nurgaliev KZH, Kulshymanova MM, Atasheva AA, Dalibaeva G, Bejsen A, Bekmurat K. Trends in prevalence major rheumatic diseases in the Republic of Kazakhstan for 2012-2016. Medicina. 2018; 3(189):17-22 https://doi.org/10.31082/1728-452X-2018-189-3-17-22
  • Kitas GD, Erb N Tackling ischaemic heart disease in rheumatoid arthritis. Rheumatology. 2003; 42:607-613. https://doi.org/10.1093/rheumatology/keg175
  • Kaplan MJ Is rheumatoid arthritis a risk factor for cardiovascular disease? Nature Clinical Practice Rheumatology. 2007; 3:260-261. https://doi.org/10.1038/ncprheum0476
  • Nurmohamed MT et al. Rheumatic diseases as risk factors for cardiovascular disease. Nederlands Tijdschrift Voor Geneeskunde. 2006; 150:1921-1924.
  • Gonzalez A et al. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? Ann. of the Rheumatic Diseases. 2008; 67:64-69. https://doi.org/10.1136/ard.2006.059980
  • Gabriel SE Heart disease and rheumatoid arthritis: understanding the risks. Ann. of the Rheumatic Diseases. 2010; 69:61-64. https://doi.org/10.1136/ard.2009.119404
  • Peters MJ et al. Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study. Arthritis & Rheumatism. 2009; 61:1571-1579. https://doi.org/10.1002/art.24836
  • Van Halm VP et al. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation. Ann. of the Rheumatic Diseases. 2009; 68:1395-1400. https://doi.org/10.1136/ard.2008.094151
  • Baghdadi LR,Woodman R.J., Shanahan E.M., Mangoni A.A. The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis. PLoSOne. 2015; 10(2):1-18. https://doi.org/10.1371/journal.pone.0117952
  • Maradit-Kremers H, Nicola PJ, Crowson CS et al. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum. 2005; 52:722-732. https://doi.org/10.1002/art.20878
  • Young A Koduri G, Baifey M et al. Mortality in rheumatoid arthritis, Increased in the early course of disease, in ischemic heart disease and in pulmonary fibrosis. Rheumatology. 2007; 46(2):350-7. https://doi.org/10.1093/rheumatology/kel253
  • Liuzzo G, Colussi C, Ginnetti F et al. C-reactive protein directly induces the activation of the transcription factor NFкВin human monocytes: a clue to pathogenesis of acute coronary syndromes? Eur.Heart J. 2001; 22:372.
  • Meune C, Touze E, Trinqurte L et al. Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analisis of cohort studies. Rheumatology. 2009; 48(10):1309-13. https://doi.org/10.1093/rheumatology/kep252
  • Peters MJ, Symmons DP, McCarey DW et al. EULAR evidencebased recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other types of inflammatory arthritis- TASK FORCE "Cardiovascular risk management in RA". Ann Rheum Dis. 2010; 69(2):325-31.
  • Klochkova GV, Popova MA Factors of cardiovascular risk for patients with immune-inflammatory joint diseases in Khanty-Mansiisky Autonomous Okrug VЕSTNIK Surgutskogo gosudarstvennogo pedagogicheskogo universiteta. 2009; 1 (4):97-104
  • Targońska-Stępniak B, Biskup M, Biskup W, Majdan M. Gender Differences in Cardiovascular Risk Profile in Rheumatoid Arthritis Patients with Low Disease Activity. Biomed Res Int. 2019; 2019:3265847. https://doi.org/10.1155/2019/3265847
  • Albrecht K. Gender-specific differences in comorbidities of rheumatoid arthritis. Z Rheumatol. 2014;73(7):607-14. https://doi.org/10.1007/s00393-014-1410-3
  • Castañeda S, González-Juanatey C, González-Gay MA. Sex and Cardiovascular Involvement in Inflammatory Joint Diseases. Clin Rev Allergy Immunol. 2017; https://doi.org/10.1007/s12016-017-8635-2